• Poor re-insurance results is expected to cause lower earnings per share. This overlooks Kiskadee a strong operation which should offset reduced earnings.
  • Hiscox continue to expand total business and at an impressive 19.9% return on equity.
  • Hiscox are currently trading at a lower than trend P/B.
  • Expected to beat earnings consensus causing a positive revaluation.

The full article can be found here.